Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia

Endocrine

Volumn 47, Issue 1, 2014, Pages 299-307

  Falhammar, Henrik ^a,b   Nyström, Helena Filipsson ^c,d   Thorén, Marja ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

21 hydroxylase deficiency; Age at diagnosis; Control; Glucocorticoid; Psychological well being index

Indexed keywords

CORTICOSTEROID; CORTISONE ACETATE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DEPRESSION; EDUCATION; ENZYME ACTIVITY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NEWBORN SCREENING; OCCUPATION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SCORING SYSTEM; SELF CONTROL; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SOCIAL ASPECT; SOCIAL LIFE; STEROID 21 MONOOXYGENASE DEFICIENCY; ADRENAL HYPERPLASIA, CONGENITAL; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SATISFACTION; SEXUALITY; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; PERSONAL SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SEXUALITY; SOCIAL CLASS; YOUNG ADULT;

EID: 84906934029     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0161-2     Document Type: Article

References (31)

1. A. Wedell, A. Thilen, E.M. Ritzen, B. Stengler, H. Luthman, Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J. Clin. Endocrinol. Metab. 78(5), 1145-1152 (1994)
2. H. Falhammar, M. Thoren, Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 41(3), 355-373 (2012). doi:10.1007/s12020-011-9591-x
3. D.P. Merke, S.R. Bornstein, Congenital adrenal hyperplasia. Lancet 365(9477), 2125-2136 (2005). doi:10.1016/S0140-6736(05)66736-0
4. P.W. Speiser, R. Azziz, L.S. Baskin, L. Ghizzoni, T.W. Hensle, D.P. Merke, H.F. Meyer-Bahlburg, W.L. Miller, V.M. Montori, S.E. Oberfield, M. Ritzen, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(9), 4133-4160 (2010). doi:10.1210/jc.2009-2631
5. H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(1), 110-116 (2007). doi:10.1210/jc.2006-1350
6. H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. J. 56(4), 601-608 (2009)
7. H. Falhammar, H. Filipsson Nystrom, A. Wedell, M. Thoren, Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285-293 (2011). doi:10.1530/EJE-10-0877
8. C.F. Mooij, J.M. Kroese, H.L. Claahsen-van der Grinten, C.J. Tack, A.R. Hermus, Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin. Endocrinol. 73(2), 137-146 (2010). doi:10.1111/j.1365-2265.2009.03690.x
9. W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M. Connell, R.J. Ross, Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95(11), 5110-5121 (2010). doi:10.1210/jc.2010-0917
10. T.S. Han, R.H. Stimson, D.A. Rees, N. Krone, D.S. Willis, G.S. Conway, W. Arlt, B.R. Walker, R.J. Ross, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia. Clin. Endocrinol. 78(2), 197-203 (2013). doi:10.1111/cen.12045
11. I. Nermoen, I. Bronstad, K.J. Fougner, J. Svartberg, M. Oksnes, E.S. Husebye, K. Lovas, Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167 (4), 507-516 (2012). doi:10.1530/EJE-12-0196
12. H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, A. Nordenskjold, K. Hagenfeldt, M. Thoren, Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 92(12), 4643-4649 (2007). doi:10.1210/jc.2007-0744
13. H. Falhammar, H. Filipsson Nystrom, A. Wedell, K. Brismar, M. Thoren, Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 168(3), 331-341 (2013). doi:10.1530/EJE-12-0865
14. A. Falorni, V. Minarelli, S. Morelli, Therapy of adrenal insufficiency: an update. Endocrine 43(3), 514-528 (2013). doi:10.1007/s12020-012-9835-4
15. L. Frisen, A. Nordenstrom, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Moller, A. Nordenskjold, Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J. Clin. Endocrinol. Metab. 94(9), 3432-3439 (2009). doi:10.1210/jc.2009-0636
16. I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453-459 (2010). doi:10.1530/EJE-10-0284
17. T.H. Johannsen, C.P. Ripa, E.L. Mortensen, K.M. Main, Quality of life in 70 women with disorders of sex development. Eur. J. Endocrinol. 155(6), 877-885 (2006). doi:10.1530/eje.1.02294
18. N. Reisch, S. Hahner, B. Bleicken, L. Flade, F. Pedrosa Gil, M. Loeffler, M. Ventz, A. Hinz, F. Beuschlein, B. Allolio, M. Reincke, M. Quinkler, Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin. Endocrinol. 74(2), 166-173 (2011). doi:10.1111/j.1365-2265. 2010.03920.x
19. U. Kuhnle, M. Bullinger, H.P. Schwarz, The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur. J. Pediatr. 154(9), 708-716 (1995)
20. M.A. Malouf, A.G. Inman, A.G. Carr, J. Franco, L.M. Brooks, Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: congenital adrenal hyperplasia. Int. J. Pediatr. Endocrinol. 2010, 253465 (2010). doi:10.1155/2010/253465
21. J. Jaaskelainen, R. Voutilainen, Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr. 89(2), 183-187 (2000)
22. A. Nordenskjold, G. Holmdahl, L. Frisen, H. Falhammar, H. Filipsson, M. Thoren, P.O. Janson, K. Hagenfeldt, Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 93(2), 380-386 (2008). doi:10.1210/jc.2007-0556
23. A. Nordenstrom, L. Frisen, H. Falhammar, H. Filipsson, G. Holmdahl, P.O. Janson, M. Thoren, K. Hagenfeldt, A. Nordenskjold, Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception. J. Clin. Endocrinol. Metab. 95(8), 3633-3640 (2010). doi:10.1210/jc.2009-2639
24. H. Falhammar, H.F. Nystrom, U. Ekstrom, S. Granberg, A. Wedell, M. Thoren, Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur. J. Endocrinol. 166(3), 441-449 (2012). doi:10.1530/EJE-11-0828
25. K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, L. Frisen, M. Thoren, A. Nordenskjold, Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum. Reprod. 23(7), 1607-1613 (2008). doi:10.1093/humrep/den118
26. U. Nygren, M. Sodersten, H. Falhammar, M. Thoren, K. Hagenfeldt, A. Nordenskjold, Voice characteristics in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. 70(1), 18-25 (2009). doi:10.1111/j.1365-2265.2008.03347.x
27. H.J. Dupuy, The psychological general well-being (PGWB) index. Assessment of quality of life in clinical trials of cardiovascular therapies (Le Jacq Publishing Inc, New York, 1984)
28. N.L. McCoy, The McCoy Female Sexuality Questionnaire. Qual. Life Res. 9(1 Supplement), 739-745 (2000). doi:10.1023/A:1008925906947
29. T.S. Han, N. Krone, D.S. Willis, G.S. Conway, S. Hahner, D.A. Rees, R.H. Stimson, B.R. Walker, W. Arlt, R.J. Ross, Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur. J. Endocrinol. 168(6), 887-893 (2013). doi:10.1530/EJE-13-0128
30. B. Bleicken, M. Ventz, A. Hinz, M. Quinkler, Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period. Endocr. J. 59(10), 931-939 (2012)
31. M. Hines, C. Brook, G.S. Conway, Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J. Sex Res. 41(1), 75-81 (2004). doi:10.1080/00224490409552215